Our customers often face complex content problems that hinder their efficiency, scalability, and customer satisfaction. These challenges cost the enterprise money, time, and risk. They often try to solve the problem by buying new software – and then wonder why they still have unacceptable levels of risk, wasted time,
Did you know that one of the best things you can do for your customers is to create less content? I know what you’re thinking. “Why is Content Rules, a company that has been creating excellent content for our customers for over 30 years, telling me to create less content?”
A few weeks ago, while perusing the New York Times I came across the article, “How Tech Giants Cut Corners to Harvest Data for A.I.” The article was written by a team of five reporters located in San Francisco, Washington, and New York. The main gist of the article is
In pharmaceutical and biotech regulatory document development, your content strategy – the business plan for how you create, manage, and deliver content – significantly impacts your ability to innovate, comply with regulations, and ultimately, bring new medicines to market. It’s understandable to think that the pharma industry can take a
What Is Content Automation and Why it is Important? Content automation is the practice of using systems to perform repetitive tasks to create content; such as formatting, data retrieval, and document assembly. Content automation in the pharmaceutical industry is often implemented for the following reasons: Reduce the time it takes
Buy this Book to learn exactly what it takes to deliver personalized experiences at scale.
Get exclusive access to Val’s thoughts and hand-picked content with our newsletter.
“*” indicates required fields